2 - 3 February 2016, Two-day congress, London, UK
2 - 3 February 2016
A two-day event providing the crowd sourced education, strategies and solutions to enable more effective funding, investment, business planning and partnering.
It will feature 'blue sky' keynote sessions, group discussions, interactive roundtables, fireside panels and structured one to one partnering.
The organisers have added a Pharma Forum Day to help UK life science Executives assess collaboration opportunities with many of the industry’s Big Pharma players.
Recognising the continued and growing importance of business development and licensing, partnerships and M&A opportunities for the UK science base, the conference is presenting sessions for major Pharma and Big Biotech BD heads to promote their external partnering and business development opportunities in their areas of disease leadership.
Companies already signed up to participate in the Pharma Forum Day includes Lilly, AstraZeneca, GSK, Pfizer, Novartis, EMD Serono, Sanofi and Ipsen Biopharm. A total of 10 slots are being offered on 3 February.